Pws Lab Results

  • May 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Pws Lab Results as PDF for free.

More details

  • Words: 1,194
  • Pages: 12
PWS lab results - acylcarnitines NTL1 Short chain acylcarnitines C2 (acetylcarnitine)

C3 (propionylcarnitine) C3-DC (malonylcarnitine C3:1 (propenoylcarnitine) C4 (isobutyrylcarnitine) C4-DC (methylmalonylcarnitine) C4-OH (hydroxybutyrylcarnitine)

HRR2

HRR3

MGN4

1.03 (<1.78)

1.33 Hn

18.61 H

170

0.55 Hn

19 (0-50)

0.02 Ln

<0.02 (<0.02) 237 0.20 (0-600) (<0.29) <0.02 (<0.03) 0.09 H

C5 (isovalerylcarnitine)

209 (0-360) C5-DC (glutarylcarnitine) 46 (0-90) C5-OH (3-OH-isovalerylcarnitine) 35 (0-60) C5:1 (tiglyl-methylcrotonylcarnitine) 19 (0-30)

0.22 Hn 0.02 (<0.06) 0.04 H

0.04 Ln 0.32 (<1.06)

1.1 H BQL (0-.2) 0.04 Ln

0.21 (<0.63) 0.03 (<0.10)

0.36 (0-.70) 0.03 Ln 0.0 (0-.11) 0.03 Ln

<0.02 (<0.02)

Medium chain acylcarnitines C6 (hexanoylcarnitine) C6-DC (adipylcarnitine/ methylglutarylcarnitine) C6-OH (3-OH-hexanolylcarnitine) C8 (octanoylcarnitine) C8-DC (suberylcarnitine)

94 H

0.08 (<0.12) 0.03 H

<0.02 (<0.02) 64 0.15 (0-180) (<0.25) 0.02 H

0.23 H

0.06 Ln 0.05 (0-.10)

0.33 (<0.76)

0.52 (0-.80) 0.12 Ln

C8:1 (octenoylcarnitine) C10 (decanoylcarnitine) C10:1 (decenolylcarnitine)

0.42 (<0.81) 77 0.14 (0-220) (<0.39) 93 0.02 Ln (0-200)

0.24 (<0.91) 0.20 (<0.91) 0.07 (<0.46)

C10:2 (decenolylcarnitine) C12 (dodecanolylcarnitine)

72 0.05 (0-200) (<0.26) C12-OH (3-OH-dodecanolylcarnitine) <0.02 (<0.02) C12:1 (dodecenolycarnitine) 46 0.02 Ln (0-240) C12:1-OH (dodecenolycarnitine)

0.07 (<0.35) 0.01 Ln 0.04 Ln (<0.37)

0.05 Ln 0.03 Ln 0.04 (0-.11) 0.39 (0-0.60) BQL Ln 0.05 Ln 0.04 Hn

Long chain acylcarnitines C14 (tetradecanoylcarnitine)

0.03 (<0.05) C14-OH (3-OH-tetradecanoylcarnitine) <0.02 (<0.02) C14:1 (tetradecenolycarnitine) 55 <0.02 (0-100) (<0.02) C14-OH (OH-tetradecenoylcarnitine) C14:1-OH (3-OH-tetradecenoylcarnitine) <0.02 (<0.02) C14:2 (tetradecadienoylcarnitine) 49 0.02 Ln (0-130) C16 (hexadecanoylcarnitine) 0.09 (<0.15) C16-OH (3-hydroxyhexadecanoylcarnitine) 8 (0-50) C16:1 (3-OH-hexadecenolylcarnitine) <0.02 (<0.06) C16:1-OH (3-OH-hexadecenolylcarnitine) <0.02 (<0.02) C18 (stearoylcarnitine) 34 0.04 (0-100) (<0.09) C18-OH (OH-oleoylcarnitine) 7 Ln C18:1 (oleoylcarnitine) 74 0.16 (0-280) (<0.27) C18:1-OH (3-OH-oleoylcarnitine) 7 <0.02 (0-50) (<0.02) C18:2 (linoleoylcarnitine) 0.09 (<0.14) C18:2-OH (3-OH-linoleoylcarnitine) <0.02 (<0.02)

0.02 Ln 0.01 (<0.05) 0.02 Ln

0.03 Ln (0-.30)

0.03 Ln 0.03 Ln

0.02 Ln

0.03 Ln

0.05 (<0.25) 0.09 H

0.09 Ln

0.06 (<0.21)

0-.14 (0-.20) BQL Ln (0-.1) 0.08 (0-.11)

0.00 Ln

0.08 (<0.45) 0.03 (<0.04) 0.04 Ln

0.06 Ln 0.03 Hn 0.03 Ln BQL Ln

Notes

* elevated C2 and C4-OH can be seen in ketosis, however he was not in a fasting state so the elevated C2 suggests a shift in the utilization of CoA from pyruvate oxidation to fatty acid oxidation * although ketosis may be present, a likely explanation for at least part of the elevated C2 is carnitine role as an acetyl group acceptor from acetyl-CoA and thus the formation of acetylcarnitine, a reaction catalyzed by carnitine acetyl-transferase. A high acetyl-CoA/CoA ratio due to an increased reliance on fatty acid oxidation inhibits pyruvate dehydrogenase (PDH) and therefore glucose oxidation. * also note that elevated C2 is a prominent feature of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency * elevated in methylmalonic acidemias and propionic acidemia * possibly elevated in multiple carboxylase deficiency/biotinidase deficiency

* elevated C4-OH and C2 can be seen in ketosis, however he was not in a fasting state which suggests shift in the utilization of CoA from pyruvate oxidation to fatty acid oxidation * elevated in short chain hydroxy acyl-CoA dehydrogenase deficiency * elevated in SUCLA2 mutation leading to mitochondrial DNA depletion, succinyl-CoA synthase deficiency in the Kreb's cycle (a distal step of the methylmalonic acid pathway), and mild methylmalo aciduria. * elevated in fasting * elevated in isovaleric acidemia

elevated in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency and multiple carboxylase deficiency/biotinidase deficiency

* beta-oxidation product of C-8 * suggests increased fatty acid omega-oxidation * elevated in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

caprylic acid elevated during fasting

lauric acid

lauric acid

myristic acid

* elevated in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional prote (TFP) deficiency palmitoleic acid

oleic acid

linoleic acid (essential unsaturated omega-6 acid)

PWS lab results - serum amino acids (see also Tyrosine)

BTS (3 d, NICU) "severe generalized hypoaminoacidemia , ? malnutrition" 1-methyl histidine 2-amino-n-butyric acid 3-methyl histidine

alanine alpha-aminoadipic acid Alpha-aminobutyrate anserine arginine argininosuccinic acid asparagine aspartic acid beta-alanine beta-aminoisobutyrate carnosine citrulline cystathionine cysteine ethanolamine gamma-aminobutyrate glutamic acid glutamine

glycine

histidine homocysteine hydroxyproline alloisoleucine isoleucine

HRR (11 m)

KRS (34 d)

0 [ND] (0)

5 Hn (05) 23 229 (148420) 3 (0-8)

323 (0-611) 0 [ND] (0) 0 [ND] (0) 24 H (0) 0 [ND] (0) 75 (0-249)

(42132) 0 (0-1) (12-72)

96 (0-152) (0-31) -- (0-7) 0 (0) 0 [ND] (0) 26 (0-92) 1 Ln (0-5) 38 (0-142) 0 Ln (0-4) 0 (0) 118 (0195) 683 (0933) 276 (0569) 100 (0142) 0 [ND] (0) 44 (0-92) (0-108)

NTN (NICU)

19 (1-42)

22 (241) 33 (149)

High

(13133) 568 (238842) 227 (104344) 76 (37-97) 0 (0-1) 0 (0-1) 45 (10-86)

leucine

lysine methionine ornithine phenylalanine ophosphoethanolamine o-phosphoserine phosphoserine proline

sarcosine (Nmethylglycine) serine

taurine threonine

tryptophan Tyrosine valine

(0-183)

(0-257) 46 (0-55) 113 (0-159) 60 0-117)

114 (30-142)

25 (945) (5-129) 62 (23-79) (0-10)

19 (0-66) (0-22) (0-22) 221 (0-430)

284 Hn (59-299)

0 [ND] (0) 203 (0-299)

139 (56-188)

177 (0-228) (0-242)

70 (0-189) 158 (20-210)

(23-71) 85 (0-150) (0-292)

(20-96) 174 (50-242)

PWS lab results - urinary amino acids BTS (3 d, NICU)

"normal"

PWS lab results - serum carnitine Serum carnitine Type NTN

Age

Supp?

Total

Esters

Free

NICU

 ?

62

6

56

SLV

UPD

5m

N

(24-100)

8

(20-88)

RN

UPD

11 y

N

(35-90)

11 (4-36)

(25-55)

HRR

11 m

Y

(32-62) (4-12)

(25-54)

MGN

6y

Y

(12-41)

3

(8-33)

Age

Supp?

Total

Esters

Free

Y

3478 H (180412)

1107

Ester/free Free/total ratio ratio 0.1 Ln? .90 Hn? 0.33 .6 (0.1-0.8) 0.25 (.09-.35) 0.07

0.75 0.64 0.8 (.70-.94)

Urinary carnitine Type HRR

13.5 m

Ester/free Free/total ratio ratio

2371 H (0.7-3.4) (77-214)

0.68

PWS lab results - electrolytes and acid base

Type

Age

BTS

del

2d

BTS

del

BTS

del

BTS

del

BTS

del

BTS

del

4 d, 12:50a 4 d, 4:40p 6 d, 5:16a 7 d, 4:10a 8 d, 2:35a

Sodiu m 137 (134144) (134144) (134144) (134144) (139146) 143 (139146)

Potassiu Chlorid m e 4.5 (3.7-5.9) 4.8 (3.7-5.9) 5.2 (3.7-5.9)

7.4 (7.3507.450)

(13-22) (13-22)

(96108)

24 (20-28)

4.2 (3.6-5.1)

104 (101111)

28 (22-32)

HRR

9d

(3.5-4.9)

HRR

11 d

(135145)

5 (4.0-6.2)

HRR

14 d

HRR

11 m

(135146)

(4.1-5.3)

HNN

4y 9m

(135148)

4.1 (3.5-5.5)

MGN

8y

MCL

(2226)

20 (13-22)

4.7 (4.1-5.3)

(138146)

144 (135148) 141 (135150)

pH

(4.1-5.3)

5y 9m

del

Bicarb

(3.7-5.9)

(136144)

BTS

107 (96110) (96110) (96110)

HCO2 total

4.4 (3.5-5.3) 4.6 (3.5-5.5)

(23-27) 101 (95105)

101 (98110) 99 (96109) 102 (95110)

(17.022.0)

(21-33) 26 (20-32) 28 (22-31)

Anion Lactic acid/ gap lactate

Calcium

Calciu m correct ed

9.8 (9-10.9)

(8.410.4)

14 (5-15)

(.5-2.2)

(1020)

1.9 (0.7-2.5) (1.121.32)

0.9 (venous <2.0, arterial <1.6)

PWS lab results - urinary organic acids HRR (11 m) 2-hydroxyisocaproic acid 0 (0 mg/g) 2-methylcitric acid 4.3 (0-8.0 mg/g) 3-methylcrotonylglycine 0 Ln (0-3.0 mg/g) 3-phenylpropionylglycine 0 (0 mg/g) 4-hydroxybutyric acid 0 (0 mg/g) 4-hydroxyphenyllactic 1.2 Ln (0-50.0 mg/g) acid ethylmalonic acid 8.5 (0-20.0 mg/g) glutaric acid 2.6 (0-10.0 mg/g) hexanoylglycine 0.8 (0-2.0 mg/g) isovalerylglycine 0 Ln (0-7.0 mg/g) methylmalonic acid 0 Ln (0-10.0 mg/g) N-acetylaspartic acid .3 (0-4.0 mg/g) orotic acid 1.0 (0-4.0 mg/g) propionylglycine 0 (0 mg/g) "unidentified peaks are present, which may be drug metabolites"

PWS lab results - thyroid

T-3 T-4 T-4, free TSH

HRR (11 m) HRR (11.5 m) 170 (48-320 ng/dL) 7.9 (5.6-16.4 ng/dL) 0.84 (not estab.) 1.3 2.15 (0.8-6.5 (.67-5.97 uU/mL) ng/dL)

Related Documents

Pws Lab Results
May 2020 4
Lab Results
May 2020 3
Lab 1 Results
November 2019 2
Lab Report - Results
June 2020 4
Me272 - Lab 4 Results
June 2020 2